Top in ID: COVID-19 vaccine efforts, journal retractions
Click Here to Manage Email Alerts
Presenters opened the National Foundation for Infectious Diseases’ Annual Conference on Vaccinology Research with a discussion on the current state of vaccine development for COVID-19. It was the top story in infectious disease last week.
Another top story was an exclusive interview with Infectious Disease News Editorial Board Member Eugene Shapiro, MD, about retracted articles on COVID-19 research and flaws with the peer-review process.
Read these stories and more in infectious disease below:
Accelerated COVID-19 vaccine effort should not mean compromises, experts say
Public-private partnerships, collaboration among researchers and knowledge of existing coronaviruses have all contributed to the accelerated development of COVID-19 vaccine candidates, according to Infectious Disease News Editorial Board Member Kathleen M. Neuzil, MD, MPH, FIDSA. Read more.
Q&A: Journal retractions 'due to a rush to publish’ information on COVID-19
As researchers work rapidly to publish research on COVID-19, major medical journals including The Lancet and The New England Journal of Medicine have retracted articles because of issues regarding data transparency and methodology. Read more.
Few health care workers have medical contraindication to flu vaccine in single-center study
Few health care personnel in a large academic health system who requested a medical waiver for the influenza vaccine had a true medical contraindication, according to findings in Infection Control and Hospital Epidemiology. Read more.
FDA rescinds EUA for hydroxychloroquine for COVID-19 patients
The FDA has rescinded the emergency use authorization for hydroxychloroquine for the treatment of COVID-19, according to a letter from RADM Denise Hinton, the FDA’s Chief Scientist. Read more.
Unnecessary antibiotic prescribing decreases in ambulatory care settings over 5-year period
The prescribing of unnecessary antibiotics in U.S. physician offices and EDs decreased slightly, from 30% to 28%, between 2010 and 2015, according to findings published in Clinical Infectious Diseases. Read more.